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A B S T R A C T
This is a protocol for a Cochrane Review (Intervention). The objectives are as follows:
To compare the effects of low carbohydrate weight-reducing diets to weight-reducing diets with balanced ranges of carbohydrates, in
relation to changes in weight and cardiovascular risk, in overweight and obese adults without type 2 diabetes (comparison 1) and with
type 2 diabetes (comparison 2).
B A C K G R O U N D
Description of the condition
The 2017 Global Nutrition Report estimates that two billion
adults worldwide are overweight or obese, and 41 million children
are overweight (Development Initiatives 2017). For the first time
inhistory,more people globally are dying from the consequences of
overeating than starvation and malnutrition (Forouzanfar 2015).
This shift has happened in the last 20 to 30 years and is thought to
be mainly due to diets that are of poor nutritional quality, high in
energy density and often ultra-processed. Such diets often result
in cumulative weight gain over time and consequently increase the
risk of cardiovascular disease, diabetes, stroke and some cancers
(Forouzanfar 2015). Globalised food systems promote over con-
sumption of these foods (Moubarac 2014; Swinburn 2011).
High body mass index (BMI) is an important modifiable risk
factor for cardiovascular disease, diabetes, kidney diseases, cer-
tain cancers and musculoskeletal conditions (Berrington 2010;
ERFC 2011; GBMRF for CD Collaboration 2014; Singh 2013;
Whitlock 2009; Zheng 2011). The disease burdens related to obe-
sity are particularly evident in low- and middle-income countries.
Cardiovascular disease deaths rose by 12.5% from 15.9 million
in 2005 to 17.9 million in 2015, and low- and middle-income
countries accounted for over three-quarters of these deaths (GBD
MCDC 2016). In Africa, between 1980 and 2014, age-standard-
ised prevalence of type 2 diabetes increased from 4.8% to 9.7%
in men and from 7.7% to 12.6% in women (NCD-RisC 2017).
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These shifting disease patterns have a major impact on individual
and family well-being, and on economies, with large direct and
indirect costs being associated with illness.
Description of the intervention
Pharmacotherapy, bariatric surgery and counselling that target
diet, physical activity, and behaviour change are used to treat adult
obesity (Dietz 2015). Due to the chronic and relapsing nature
of obesity and its related conditions, current guidelines for the
treatment of obesity recommend comprehensive management ap-
proaches that aim to achieve long-term weight reduction. This in-
cludes intensive lifestyle intervention characterised by dietary re-
striction, increased physical activity, and behavioural management
as first-line treatment (Dietz 2015; Jensen 2014). Importantly,
there is not a ’one-size-fits-all’ weight-reducing diet and different
diets work for different people, based on preferences and ease of
adherence (Jensen 2014; Johnston 2014).
The public, families and health professionals face an often dizzy-
ing array of weight-reducing diets, many of which have been com-
mercialised as books, seminars, diet food products, supplements
and other related products. These include, but are not limited to,
various versions of low carbohydrate diets (for example, Atkins
diet (Atkins 1999)), low fat or so-called ’balanced diets’, very low
fat diets (for example, Ornish diet (Ornish 2001)), and low gly-
caemic diets (for example, South Beach diet (Agatston 2003)).
Nutrients are needed by the body in small (i.e. micronutrients
such as vitamins and minerals) or large amounts (i.e. macronu-
trients) for growth, repair and optimal functioning (Lichtenstein
2005). Total daily energy intake is made up of the sum of the
energy provided by the three macronutrients (i.e. carbohydrate,
protein and fat). Per gram of macronutrient, carbohydrates and
protein each provides about 17 kilojoules, while fat provides about
37 kilojoules (Carreiro 2016). Carbohydrates are primarily con-
tained in grains, cereals and sugar, and in the digestive tract are
broken down into glucose. Carbohydrates are the largest nutrient
class, and traditionally, the greatest energy source. If energy intake
exceeds energy requirements, excess carbohydrates will be mainly
stored in the liver as glycogen for later use or be converted to fatty
acids when glycogen stores are saturated. In contrast, if the diet
contains limited amounts of carbohydrate, the liver converts fat
into fatty acids and ketones to replace glucose as energy source
(Paoli 2013).
Low carbohydrate diets are a broad category of weight-reduc-
ing diets and programmes that manipulate and restrict macronu-
trient (carbohydrate, protein, fat) intake (Astrup 2004; Bazzano
2012; Campbell 2012; Hession 2009). There are no consistent
and widely accepted definitions of these diets and different de-
scriptions are used, such as ’low carbohydrate, high protein’ or ’low
carbohydrate, high fat’, depending on the macronutrient manipu-
lation and focus. In practice, low carbohydrate diets are applied in
different ways, but generally restrict grains, cereals and legumes,
and other foods that contain carbohydrates, such as dairy, most
fruit and certain vegetables. The energy required is then typically
replaced with food higher in fat and protein, such as meats, eggs,
cheese, butter, cream and oils - many of which are animal source
foods. Some low carbohydrate diets recommend eating as desired,
while others apply restrictions to total energy intake (Atkins 2011;
Campbell 2012).
Conventional authorities such as the European Food Safety Au-
thority (EFSA 2017), American Institute of Medicine Food and
Nutrition Board (IOM 2005), Australian National Health and
Medical Research Council together with the New Zealand Min-
istry of Health (NHMRC 2006), and the Nordic Council of Min-
isters,NordicCommittee of SeniorOfficials for Food Issues (NNR
2012), as well as the UK’s Scientific Advisory Committee on Nu-
trition (SACN 2015), have recommended 45% to 65% of total
energy as the appropriate carbohydrate intake for adults. Thus,
some people regard low carbohydrate diets to be those with carbo-
hydrate intakes below 45% of total energy. Some published defi-
nitions of low carbohydrate diets disregard the official recommen-
dations, and use an upper limit of 40% of total energy from car-
bohydrates as indicative of a low carbohydrate diet (Frigolet 2011;
Wylie-Rosett 2013). In absolute, rather than proportional terms,
low carbohydrate diets have been defined as having less than 200 g
of carbohydrate (Frigolet 2011), while some disagree with this lib-
eral definition, preferring to distinguish between ’non-ketogenic
low carbohydrate diets’ as containing 50 g to 150 g of carbohy-
drates, and ’ketogenic low carbohydrate diets’ (or very low carbo-
hydrate diets) as having a maximum of 50 g of carbohydrates, with
this latter variant seen by some as being more effective for weight
loss (Westman 2007; Yancy 2004). Ketogenic diets are charac-
terised by a high production of ketones in the liver as an alterna-
tive energy source, as well as high levels of ketones in the blood
(ketonaemia) and urine (ketonuria) when fat or protein intake is
very high and carbohydrate intake is very low (less than 50 g/day)
(Paoli 2013).
Weight-reducing diets aligned with current dietary recommenda-
tions are often referred to as ’low fat diets’ or ’balanced, weight-
reducing diets’, and will be referred to as ’balanced diets’ in this
review (British Dietetic Association 2013). Globally, current di-
etary recommendations - in terms of macronutrients, micronutri-
ents, food choices and dietary patterns - are generally consistent,
and governmental bodies from Europe, the USA, Australia and
Nordic countries recommend that 45% to 65% of total energy in-
take should be provided by carbohydrates, between 10% and 35%
by protein and between 20% and 35% by fat (EFSA 2017; IOM
2005; NHMRC 2006; NNR 2012). There is room for flexibility
within these ranges from lower to higher intakes of carbohydrate,
fat and protein. These dietary recommendations are accompanied
by information on ’better food’ choices; improving the quality
of carbohydrates (e.g. whole grains versus refined grains), protein
(e.g. fish versus processed meat) and fat (e.g. olive oil versus but-
ter); as well as on maintaining a healthy body weight by aiming to
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keep energy intake and energy expenditure balanced.
Nutrition recommendations are moving away from macronutri-
ent-focused, single food and single nutrient messages towards
recommendations about dietary patterns and ‘total diets’ (NICE
2014; NNR 2012; USDA 2014). This has been driven mainly
by the lack of clear and consistent associations between individual
nutrients (micronutrients and macronutrients) and disease risk,
limitations of single nutrient trials and greater successes of ’total
diet’ or dietary pattern interventions.
Dietary patterns can be defined as “the quantities, proportions,
variety, or combination of different foods, drinks, and nutrients
(when available) in diets, and the frequency with which they are
habitually consumed” (USDA 2014). Current evidence supports
associations between some dietary patterns and lower risk of obe-
sity and chronic diseases, especially type 2 diabetes, cardiovascular
disease, hypertension, and certain cancers (DGAC 2015; USDA
2014). For example, systematic reviews of large long-term stud-
ies show that several dietary patterns are consistently and equally
associated with a lower risk of developing type 2 diabetes in the
future (Alhazmi 2014; Esposito 2014; Koloverou 2014). These
dietary patterns have different macronutrient compositions, but
share several common components, including fruit, vegetables,
wholegrains, legumes, nuts, healthy oils, adequate proteins (such
as seafood and lean meat), reduced intake of red and processed
meats and sugar-sweetened beverages, and little or moderate al-
cohol (Ndanuko 2016; NNR 2012; USDA 2014). It has been
suggested that carbohydrate avoidance and the resultant food re-
strictions typical of low carbohydrate diets make a dietary pattern
that is nutrient- and fibre-rich, diverse and promotes good health
difficult to achieve (USDA 2014).
How the intervention might work
Energy balance and body weight regulation is complex and in-
teractive, and questions on certain components of energy balance
and their interactions - especially over the longer term - are yet
to be answered (Hall 2012). The first law of thermodynamics
and evidence from various types of studies over the past 50 years,
including randomised controlled trials (RCTs), support the view
that weight loss occurs when the amount of kilojoules consumed
during eating and drinking is less than the amount of kilojoules
expended over weeks or months (ACC/AHA 2013 Full Report;
Hall 2011; Hall 2012; Hall 2015; Jensen 2014). Thus, a plausible
mechanism whereby low carbohydrate diets enable weight loss is
by achieving a sustained energy deficit over time even when ad-
vice to explicitly restrict energy intake is not provided. When peo-
ple eliminate and restrict carbohydrate-rich foods, they are more
likely to reduce energy intake because they eat less food (Brehm
2003; Sondike 2003). Related mechanisms reported in the liter-
ature include a reduction in appetite with low carbohydrate diets
possibly related to the increased intake of fat and production of
ketones (Boden 2005; Nordmann 2006; Westman 2007). Since
total energy intake is known to drive changes in body weight, its
role must be considered when examining the effect on any diet on
weight changes.
Some literature indicates that certain macronutrients may have
metabolic advantages over others, more specifically that lower car-
bohydrate intake is more effective for weight loss, independent of
energy intake (Atkins 2011;Westman 2007).However, it has been
proposed that when proportions of macronutrients in the diet are
changed, rapid physiological adaptations occur that aim to match
metabolic fuel selection to the diet. Changes in body composition
and energy expenditure may be minimised by these adaptations.
In this scenario, in the shorter term, all reduced energy diets would
have a similar effect on loss of body fat (Hall 2011).
Literature on low carbohydrate diets also suggest that the reduced
insulin secretion resulting from a low carbohydrate diet causes
greater release of adipose tissue free fatty acids, fat oxidation and
energy expenditure, and increased loss of body fat compared to re-
stricting fat intake (Ludwig 2014; Taubes 2007; Westman 2007).
A study in 19 obese adults confined to a metabolic ward demon-
strated that an equal kilojoule-selective reduction in dietary fat
resulted in no changes in insulin secretion, fat oxidation or energy
expenditure and a greater net fat loss when compared to restricting
carbohydrates by the same amount, which resulted in decreased
insulin secretion, increased fat oxidation and decreased energy ex-
penditure (Hall 2015).
According to recent clinical guidelines for obesity, a high qual-
ity systematic review, a scientific report to inform dietary guide-
lines and a recent six-month randomised controlled feeding trial,
a number of different diets may lead to weight loss over the short
term if they achieve a sustained energy deficit, but some of these di-
ets may be more advantageous than others for maintaining longer-
term cardiovascular and metabolic health (DGAC 2015; Jensen
2014; Johnston 2014; Wan 2017). There is evidence that weight
loss of 5% and more, or BMI reduction of at least 5%, may result
in clinically meaningful improvements in cardiometabolic health
following dietary regimens (Brown 2016; Truby 2006;Wald 2012;
Wing 2010).
Adherence and weight maintenance
Poor dietary adherence has been regarded as one of the reasons
popular and traditional dieting strategies are unsuccessful, and it
is well known that adherence to nutrition counselling by study
participants varies widely. Evidence from quality RCTs, system-
atic reviews and other study designs suggest that adherence to
diets is a primary driver of weight loss success, regardless of the
macronutrient composition, and may explain a considerable part
of whether or not dieters are able to achieve energy deficit for
weight loss (Alhassan 2008; Dansinger 2005; Hall 2011; Johnston
2014; Sacks 2009). Dietary intake is difficult to measure accu-
rately, and fidelity of application of dietary assessment methods
varies widely across studies (Shim 2014), which may introduce a
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lot of variation into the assessment of adherence. Consequently,
data on adherence to assigned diets is often lacking in weight loss
trials. Also, keeping the weight off once lost is also a considerable
challenge in treating obesity, with most people tending to relapse
(Dietz 2015). Indeed, a systematic review including 56 RCTs re-
ported that dieting to lose weight is most often over weeks,months
or years, and it is challenging for most people to maintain the
weight lost over the long term (Collins 2013). Thus, ease of adher-
ence to weight-reducing diets is a key factor to consider. It is also
necessary to consider the time-dependant nature of the relation-
ship between diet and weight change when examining the effect
of diets on weight change. Trials typically have different periods of
follow-up, and different frequencies or intervals of study contacts
and measurement. Tay 2015 indicated that changes sustained over
a 12-month period reflects durability of effects over the long term.
Why it is important to do this review
The public spends considerable amounts of money and time on
trying to diet, on books about diet, and on products and foods to
enhance weight loss. It is therefore important to examine scientific
evidence behind the claims made.
Some advocates claim low carbohydrate diets decrease cardio-
vascular disease and diabetes risk profiles for low carbohydrate
diets: reducing triglycerides, increasing high-density lipoprotein
(HDL) cholesterol and improving glycaemic control over one
year (Stern 2004); improving triglycerides, HDL cholesterol and
glycaemic control over four years (Wing 2010); and improv-
ing aortic stiffness over four weeks (Syed-Abdul 2018). How-
ever, the diets are not without potential side effects. These in-
clude gastrointestinal disturbances, such as flatulence, indiges-
tion, constipation or diarrhoea over the short term (Bhardwaj
2017; Brinkworth 2009a; Saslow 2014); and increasing low-den-
sity lipoprotein (LDL) cholesterol and non-HDL cholesterol over
12 months (Brinkworth 2009b; Wan 2017). Some participants
report mood disturbance and impaired ability to concentrate
(Brinkworth 2009c; Halyburton 2007). Other side effects of low
carbohydrate diets include lack of appetite, bad breath, headaches,
muscle cramps, general weakness and hair loss (Foster 2010; Rio
2001; Yancy 2004).
A prospective cohort study and meta-analysis that combined 25-
year follow-up of the Atherosclerosis Risk in Community (ARIC)
data (USA) and seven other cohort studies (USA, Europe, Asia
and multinational) assessed the association between carbohydrate
intake and mortality (Seidelmann 2018). Findings indicate that
both high and low carbohydrate diets increased mortality, with
lowest risk observed among those who consumed a diet containing
50% to 55% carbohydrates. The low carbohydrate dietary pat-
terns that favoured animal fat and protein sources were associated
with higher mortality, while those that favoured plant-based foods
were associated with lower mortality. Additionally, diets very high
in animal source foods could pose a significant threat to environ-
mental sustainability (Sabate 2014; Soret 2014).
The debate on effective and safe diets for treating obesity con-
tinues. Many trials and systematic reviews involving obese people
(with and without comorbidities) and of varying methodological
quality have assessed the effects of low carbohydrate diets onweight
and other risk factors. Many show little or no clinically important
difference in weight loss of up to two years follow-up. A systematic
review of eight RCTs found that improvements in psychosocial
outcomes occur in participants on short- and longer-term weight
loss programmes, regardless of the macronutrient composition of
the diet (Ghoch 2016). However, low carbohydrate weight-reduc-
ing diets continue to be widely promoted, marketed and commer-
cialised as being more effective for weight loss, and healthier, than
weight-reducing diets that have ’balanced’ or macronutrient com-
positions in line with current global dietary recommendations.
Healthcare officials argue that very restrictive carbohydrate diets
do not promote behaviour changes that foster varied, nutrient-
and fibre-rich dietary patterns (USDA 2014), known to reduce
risks of cardiovascular disease, hypertension, type 2 diabetes and
certain cancers. Extreme restriction or excess of macronutrients, as
advised with very low carbohydrate diets, instead promote a way
of eating that is likely to result in an imbalance of macronutrient
intake, suboptimal micronutrient intake and increased disease risk
over time.
Previously, we took stock of existing systematic reviews on low
carbohydrate diets for adults wanting to lose weight. We found 50
existing reviews (last search date: 3March 2014), with a number of
shortcomings as reported in Naude 2014. This exercise helped us
to identify a gap and inform the protocol for our earlier systematic
review and meta-analysis of RCTs (Naude 2014). This Cochrane
Review will be a fresh edition to Naude 2014, by taking into
account new eligible trials, and comments and criticisms generated
by the earlier work.
O B J E C T I V E S
To compare the effects of low carbohydrate weight-reducing diets
to weight-reducing diets with balanced ranges of carbohydrates, in
relation to changes inweight and cardiovascular risk, in overweight
and obese adults without type 2 diabetes (comparison 1) and with
type 2 diabetes (comparison 2).
M E T H O D S
Criteria for considering studies for this review
Types of studies
4Low carbohydrate versus balanced carbohydrate diets for reducing weight and cardiovascular risk (Protocol)
Copyright © 2019 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
We will include parallel-arm individual- and cluster-randomised
controlled trials (RCTs) that had an active weight-reducing inter-
vention phase for at least 12 weeks. According to Jensen 2014,
obese individuals on a moderately restricted energy intake can
potentially lose between six and eight kilograms, or five to ten
per cent of initial body weight (clinically meaningful) over a six-
month period. From this we surmise that it would be plausible to
lose five per cent of initial weight over a three-month period, but
not a shorter period. Twelve weeks is, according to the UK Na-
tional Institute for Health and Care Excellence (NICE), the stan-
dard length for most commissioned dietary interventions (Ahern
2017; NICE 2014). Following up participants after the interven-
tion ended can be of any duration.
We will exclude quasi-randomised trials (that is, trials that used an
inadequate method of randomisation, such as alternation or date
of birth). We will include cross-over trials where the first phase
was 12 weeks or longer, and where data for the first phase per
group are available. We will exclude cross-over trials that do not
meet this criteria due to the possible period and carry-over effects
that would arise with the eligible dietary interventions, condition
(overweight and obesity) and outcomes in this review, with these
not being easily reversible as required for a valid cross-over design
(Younge 2015).
We will only include studies with a weight maintenance phase if
the preceding weight-reducing phase is for 12 weeks or longer,
and relevant data from this phase are available. We will separate
analyses for weight-reducing and weight maintenance phases.
Types of participants
We will include adults (18 years and older) who are overweight
or obese (as defined by study authors), with or without type 2
diabetes mellitus, and with or without cardiovascular conditions
or risk factors such as hypertension or dyslipidaemia, as defined
by trial authors.
We will exclude studies where pregnant and lactating women were
included, as well as, studies in people with specific medical condi-
tions such as bipolar disorder, polycystic ovary syndrome, chronic
renal disease etc.
We will include studies involving a subset of eligible participants
(for example, adults and children, as defined by authors) if results
were reported separately for the eligible subset (for example, those
≥ 18 years). If not, we will only include such studies if ≥ 80% of
the baseline sample were eligible for our review (for example, aged
≥ 18 years). We will exclude data from such studies in sensitivity
analyses to test the robustness of the primary meta-analyses.
Types of interventions
Treatment diet
We will include RCTs investigating low carbohydrate weight-re-
ducing diets where the diets were explicitly implemented for the
primary purpose of reducing weight, with or without explicit ad-
vice to restrict total energy intake.
Control diet
We will include RCTs where the control adheres to the criteria
of weight-reducing diets, with carbohydrate content within the
balanced range of 45% to 65% of total energy, where the diets
were explicitly implemented for the primary purpose of reducing
weight, with or without advice to restrict total energy intake.
Wewill include studieswhere dietswere implemented by provision
of advice, foods or both. However, we will exclude studies with
the following:
• Treatment diet has carbohydrate content ≥ 45% of total
energy or > 150 g per day.
• Treatment and control diets are different in some other
respect that may influence the predefined outcomes, except for
total energy intake.
• Treatment or control diets are not adequately defined (and
could not be obtained from study authors) or where the control
diet is ‘no dietary intervention’.
• Diets are combined with any other cointerventions (e.g.
exercise, pharmacological, surgical) where these differ by group.
• Dietary interventions have an exclusive focus on energy
restriction (i.e. no macronutrient manipulation was explicitly
instituted).
• Interventions focus solely on specific foods (e.g. oats), food
groups (e.g. dairy) or food components (e.g. plant sterols), or
where meal replacements or supplements are part of the diets and
are different in the diets being compared.
• Participants are selected based on a possible prognostic
variable (for example, genotype).
Types of outcome measures
We will not exclude studies on the basis of outcomes measured.
However, we will exclude studies measuring only immediate meal
responses (e.g. postprandial changes in blood sugar), and not
longer-term physiological responses to diet.
Primary outcomes
• Change in body weight (kg) from baseline
• Number of participants per group with weight loss of at
least 5% from baseline
We will assess the primary outcomes at short-term (3 months to
< 12 months) and long-term (≥ 12 months) follow-up.
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Secondary outcomes
Clinical
• Change in body mass index (BMI; kg/m2) from baseline
• Number of participants per group with reduction in BMI
of at least 5% from baseline
We will assess these clinical outcomes at short-term (3 months to
< 12 months) and long-term (≥ 12 months) follow-up.
• Change in diastolic blood pressure (mmHg)
• Change in systolic blood pressure (mmHg)
• All-cause mortality
• Cardiovascular mortality
• Non-fatal myocardial infarction
• Non-fatal stroke
• Diagnosis of type 2 diabetes mellitus (as reported by study
authors)
We will assess these clinical outcomes at long-term (≥ 12 months)
follow-up.
Laboratory
• Change in glycated haemoglobin (HbA1c) (%)
• Change in serum low-density lipoprotein (LDL) cholesterol
(mmol/L)
• Change in serum high-density lipoprotein (HDL)
cholesterol (mmol/L)
• Change in serum non-HDL cholesterol (mmol/L)
• Change in serum total cholesterol (mmol/L)
• Change in serum triglycerides (mmol/L)
We will assess these laboratory outcomes at long-term (≥ 12
months) follow-up only.
Adverse effects
Participant-reported adverse effects, specifically with regards to
lack of appetite, bad breath, weakness, headaches, gastrointesti-
nal problems (constipation, diarrhoea, flatulence, indigestion) and
psychosocial problems (mood disturbances) at any time point,
limited to those described in included studies.
Search methods for identification of studies
Electronic searches
Wewill identify RCTs through systematic searches of the following
bibliographic databases.
• Cochrane Central Register of Controlled Trials
(CENTRAL), in the Cochrane Library
• MEDLINE (PubMed)
• Embase (Ovid)
• Web of Science Core Collection with Indexes = SCI-
Expanded, SSCi, CPCI-S (Clarivate Analytics)
We will adapt the preliminary search strategy for MEDLINE
(PubMed) for use in the other databases (Appendix 1).
We will also conduct a search of ClinicalTrials.gov (
www.ClinicalTrials.gov), and the WHO International Clinical
Trials Registry Platform ( ICTRP) Search Portal for ongoing and
unpublished trials ( apps.who.int/trialsearch).
We will search all databases from their inception to the present,
and we will impose no restriction on language of publication or
publication status. When necessary, we will seek translations.
Searching other resources
Wewill check reference lists of all included studies and any relevant
systematic reviews identified for additional references to trials. We
will also examine any relevant retraction statements and errata for
included studies.
Data collection and analysis
Selection of studies
We will import all deduplicated search records into Covidence
(Covidence). Two review authors will independently screen the
titles and abstracts of these records to identify all potential eli-
gible studies. Discrepancies in first-line screening choices will be
resolved by discussion among at least two review authors. We will
retrieve the full-text report for each record that the screeners think
is potentially eligible, and two review authors (CN, KN, AS, MS,
TY, MR) will independently screen all full-texts, identify stud-
ies for inclusion, and identify and record reasons for exclusion of
the ineligible studies. We will resolve any disagreement through
discussion or, if required, we will consult a third review author
(PG or JV). We will identify and exclude duplicates and collate
multiple reports of the same study so that each study, rather than
each report, is the unit of interest in the review. We will record the
selection process in sufficient detail to complete a PRISMA flow
diagram and ’Characteristics of excluded studies’ table (Moher
2009). Studies where full reports (published or unpublished) are
not available (e.g. conference abstracts), or where there is unclear
or missing information (that cannot be obtained from study au-
thors) so that we cannot confirm or refute study eligibility, will be
placed with a reason in the ’Studies awaiting classification’ table.
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Data extraction and management
To extract study characteristics and outcome data, we will create
a data collection form in Covidence, and pilot it on at least two
included studies. Data from each included study will be extracted
independently by two review authors (CN,KN,AS,MS,TY,MR).
We will contact the study authors when reported information is
unclear or contradictory, or when important data are missing. We
will extract information on the following.
• Methods: authors’ contact details, type of record (e.g.
journal article, thesis), study design, study population, study
dates, total duration of the intervention and follow-up duration
after the intervention where relevant, details of ’run in’ periods
where relevant, number of study centres and location, study
setting, method of recruitment, number of study arms,
description of eligible study arms, outcome used for sample size
calculation, unit of allocation, number randomised per study
arm (for individually-randomised trials), number of clusters and
number of participants per cluster who consented (for cluster-
randomised trials), number of withdrawals and those lost to
follow-up, number completed and analysed, other relevant notes
on the methods.
• Participants: inclusion and exclusion criteria, age, gender
(number of males and females per group), baseline body weight
status, other baseline cardiovascular disease risk factors and
potential confounders, any group differences.
• Interventions: treatment diet, control diet, implementation
or delivery of diets, dietary intake assessments (e.g. what, how
frequent, by whom), concomitant interventions.
• Outcomes: primary and secondary outcomes specified and
collected at relevant time points, data on adherence to the
interventions, and whether or not primary study authors
analysed results separately according to gender.
• Notes: study funding, conflicts of interest declarations of
study authors, and other relevant notes.
For outcomes, we will extract change data (change from baseline
to outcome assessment per group) where possible, with relevant
data on variance for treatment and control arms and numbers of
participants per arm at that time point. Where change data are not
available, we will extract and use data at study end (end values),
or other relevant time points, along with variance and number of
participants per arm at that time point. Where possible, we will
convert variables to comparable units to allow pooling of data, if
appropriate.
We will measure adherence as the agreement between the pre-
scribed diets and the reported dietary intakes in included studies.
We will extract the prescribed and reported total energy intake
(kilojoules) at each time point in each group. We will calculate ad-
herence to macronutrients as the difference between the reported
and prescribed distributions of energy intake (percentage of total
energy) from carbohydrate, fat and protein at the relevant time
points, using the Mahalanobis distance equation (Mahalanobis
1936). This equation is useful for measuring the similarity be-
tween a set of actual conditions relative to a set of ideal conditions
(Rencher 2002). The equationwill generate an arbitrarymacronu-
trient adherence score representing the degree of deviation from
the prescribed goals for macronutrients in the treatment and con-
trol groups, as follows: macronutrient adherence score =
√
[(mean
reported % carbohydrate of total energy - prescribed % carbohy-
drate of total energy) + (mean reported % fat of total energy -
prescribed % fat of total energy) + (mean reported % protein of
total energy - prescribed % protein of total energy)].
A lower score indicates better adherence and a higher score, poorer
adherence. We will report macronutrient adherence scores per
study per time point by group for energy (kilojoules), total carbo-
hydrate (percentage of total energy), protein (percentage of total
energy) and fat (percentage of total energy).
We will resolve disagreements by consensus or by involving a third
review author. We will export data from Covidence and import it
into the latest version of ReviewManager (Review Manager 2014).
We will complete the ’Characteristics of included studies’ table
for all included studies. We will use key items from the TIDieR
checklist (Hoffman 2014) to aid description, interpretation and
discussion of the results. Brief details of ongoing studies will be
reported in the ’Characteristics of ongoing studies’ table, and these
studies will be considered for inclusion in a future update of the
review.
Assessment of risk of bias in included studies
Two review authors (CN, KN, AS, MS, TY) will independently
assess risk of bias for each study using the criteria outlined in
the Cochrane Handbook for Systematic Reviews of Interventions (
Higgins 2011). We will resolve any disagreements by discussion
or by involving another review author (MR, PG or JV). We will
assess the risk of bias according to the following domains.
• Selection bias: random sequence generation and allocation
concealment.
• Performance bias: blinding of participants and personnel.
• Detection bias: blinding of outcome assessment.
• Attrition bias: incomplete outcome data.
• Reporting bias: selective outcome reporting.
• Other bias.
We will evaluate cluster-randomised trials according to the follow-
ing criteria (Higgins 2011).
• Recruitment bias - were participants included in the study
after the clusters were randomised?
• Baseline imbalances - were there substantial differences in
important characteristics between clusters, or between
participants within a cluster?
• Loss of clusters - were clusters omitted from the analysis, or
were there any missing outcomes for individuals within clusters?
• Incorrect analysis - did the study authors fail to take
clustering into account when performing the analysis?
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We will judge each potential source of bias as ’high’, ’low’ or ’un-
clear’ using the criteria in the Cochrane Handbook for Systematic
Reviews of Interventions (Higgins 2011), and provide reasons for
our judgements in the ’Risk of bias’ table. We will summarise the
’Risk of bias’ judgements across different studies for each of the
domains listed. Where information on risk of bias relates to un-
published data or correspondence with study authors, we will note
this in the ’Risk of bias’ table. Where different outcomes have dif-
ferent risks of bias, we will indicate that in the ’Risk of bias’ table,
as appropriate.
Measures of treatment effect
For dichotomous data, we will use the number of events as the
numerator and the total sample size per outcome as the denomina-
tor in each relevant comparison group and compute the risk ratio
(RR) (available case data). For continuous data, we will report re-
sults per outcome as the difference in the mean change (and if not
available, the difference in end values) between the treatment and
control groups, and compute the mean difference (MD) (available
case data). We will enter data presented as a scale with a consistent
direction of effect. We will use the latest Review Manager version
to conduct meta-analyses for each outcome, where appropriate, to
determine a pooled effect of low carbohydrate diets compared to
balanced carbohydrate diets. We will narratively describe skewed
data reported as medians and interquartile ranges.
Unit of analysis issues
In the case of multiple intervention groups, we will select one
pair of interventions (treatment and control) that is most relevant
to this systematic review question. For cluster-randomised trials
that did not consider adjustments for clustering, we will reanalyse
where possible, following the method of adjusting for clustering,
taking into account the correlated nature of within-cluster data,
as described in the Cochrane Handbook for Systematic Reviews of
Interventions (Higgins 2011).Where a study reports outcome data
for more than one time point within our time point categories
(3 months to < 12 months; and ≥ 12 months), we will use the
longest time point (for example, where results are available at 3
months and 5 months, we will only use the 5 months data).
Dealing with missing data
We will contact study authors or sponsors to clarify key study
characteristics and obtain missing numerical outcome data, where
needed. Where study authors have not reported all relevant statis-
tics per outcome (for example, sample size, mean change and stan-
dard deviation of change per group), we will calculate or estimate
the required data from other reported statistics using formulas
specified in the Cochrane Handbook for Systematic Reviews of Inter-
ventions (Higgins 2011), if possible. If we cannot calculate or es-
timate these statistics with reasonable confidence, we will contact
the authors by email. Where we do not receive a response we will
not impute the missing values but will report the available results
narratively or in a table, as appropriate. For interventions in which
there is substantial attrition (15% or more for at least one of the
groups) of study participants, we will report the attrition rate and
perform sensitivity analyses excluding these studies.
Assessment of heterogeneity
We will examine heterogeneity per outcome firstly by visual in-
spection of the forest plots (i.e. we will look at physical overlap
of confidence intervals across the included studies). Secondly, we
will assess statistical heterogeneity among the intervention effects
across the included studies in each meta-analysis as follows.
• Chi2 test for heterogeneity.
• I2 statistic to quantify heterogeneity.
• Tau2 statistic to measure the extent of heterogeneity.
In our meta-analyses we will consider substantial heterogeneity as
an I2 value of greater than 50% and either a Chi2 of less than 0.1
or Tau2 greater than 0. In meta-analyses where we find substan-
tial heterogeneity, we will perform prespecified subgroup analyses
on outcomes in the ’Summary of findings’ tables, as data allows.
Where we identify unexplained substantial heterogeneity, we will
not pool results into an overall effect estimate but rather present
the individual effect sizes per study for the specific outcome.
Assessment of reporting biases
If data per comparison and outcome allow us to pool more than 10
studies, we will with a funnel plot explore the possibility of small
study biases for the primary outcomes. In the case of asymmetry,
we will consider various explanations such as publication bias,
poor study design and the effect of study size.
Data synthesis
We will use a random-effects model for meta-analyses since we
anticipate heterogeneity between included studies due to varia-
tions in the composition of weight loss diets, adherence to di-
ets, intervention duration and dietary assessment methodology.
For dichotomous outcomes, we plan to use the Mantel-Haenszel
method, unless the number of events are not available but esti-
mates of effect measure and its standard error are, in which case we
will use the inverse variance method. For continuous outcomes,
we will use the inverse variance method.
Wewill analyse trials in overweight and obese participants without
(comparison 1) and with type 2 diabetes (comparison 2) separately
where possible as the presence of diabetes is likely to influence the
effects of the diets.
We will assess the comparability between individually-randomised
trials and cluster-randomised trials with sensitivity analyses, where
data allow by first pooling cluster- and individually-randomised
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trials and then pooling only studies that randomised individual
participants.
We will analyse outcome data at the time point ≥ 12 months,
because it captures sustainability of effects on weight loss, clinical
as well as laboratory outcomes. However, for the weight and BMI
outcomes, we will also analyse data at the time point 3months to <
12 months, as many people going on diets are especially interested
to know how fast they would be losing weight.
We will preferentially extract and use data from trials’ intention-
to-treat (ITT) analyses (as reported by trial authors) in all our
meta-analyses. By ITT, we mean that participants who were ran-
domised were analysed according to the group to which they were
randomised; however, if there are missing data we will not perform
any imputations.
’Summary of findings’ table
Based on the methods described in the Cochrane Handbook for
Systematic Reviews of Interventions (Higgins 2011), we will prepare
two ’Summary of findings’ tables, one for each comparison. We
will include the following outcomes measured from baseline to≥
12 months in these tables: change in body weight (kg); number
of participants per group with weight loss of at least 5%; cardio-
vascular mortality; change in diastolic blood pressure (mmHg);
change in HbA1c (%); change in serum LDL cholesterol (mmol/
L); as well as participant-reported constipation at any time point.
We will use the GRADE system to rank the certainty of the evi-
dence as it relates to the studies which contribute data to themeta-
analyses for the prespecified outcomes, using GRADEprofiler (
GRADEpro) software ( www.gradepro.org). TheGRADE tool in-
cludes five considerations (study limitations, inconsistencies of re-
sults, imprecision, indirectness and publication bias) to assess the
certainty of the evidence.
We will justify all decisions to downgrade the quality of evidence
using footnotes, and we will make comments to aid readers’ un-
derstanding where necessary.
Two review authors (from CN, AS, KN) will make judgements
about evidence certainty, with disagreements resolved by discus-
sion, and involving a third review author where needed.
We plan to extract study data, format our comparisons in data
tables and prepare a ’Summary of findings’ table before writing the
results and conclusions of our review. An example of a ’Summary
of findings’ table is included as Table 1.
Subgroup analysis and investigation of heterogeneity
We plan to carry out the following subgroup analyses for the pri-
mary outcomes, to explore the stability of findings in different
study subgroups, as follows.
• By extent of carbohydrate restriction (i.e. very low
carbohydrate or ketogenic diets: carbohydrate prescription of ≤
50 g per day or < 10% of total daily energy intake from a
nominal 8400 kilojoule (approximately 2000 kcal) diet; and
non-ketogenic low carbohydrate diets: > 50 g to 150 g per day or
< 45% of total energy intake).
• By similarity of total energy prescription (i.e. studies with
substantial differences in daily total energy prescription (> 500
kilojoules) in treatment and control groups, studies with similar
energy intake prescribed in treatment and control groups, studies
with unknown and unrestricted energy intake prescribed in
treatment and control groups).
• By diagnosed cardiovascular event or disease (i.e. studies in
people with no events or disease, studies in people with events or
disease, and studies in people with and without events or disease).
• By gender.
Sensitivity analysis
We plan to carry out sensitivity analyses for primary outcomes,
assessing the effect of:
• overall low risk of bias (i.e. first pool all relevant studies per
outcome, and then pool only studies with overall low risk of
bias) by using the following domains as markers: random
sequence generation, allocation concealment, incomplete
outcome data, selective outcome reporting;
• attrition bias (i.e. first pool all relevant studies per outcome,
and then pool only studies with < 15% missing data from the
total initial sample);
• studies including only a subset of eligible participants for
this review (i.e. first pool all relevant studies per outcome, and
then pool only studies that included only participants eligible for
inclusion in this review); and
• clustering (i.e. first pool all relevant studies per outcome,
and then pool only studies that randomised individual
participants); and
• source of funding (i.e. first pool studies with all funding
sources, and then pool only studies without diet/food industry
funding).
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A D D I T I O N A L T A B L E S
Table 1. Example ’Summary of findings’ table
Low carbohydrate versus balanced carbohydrate weight-reducing diets for 12 months or longer in overweight and obese adults
without type 2 diabetes
Participants or population: overweight and obese adults without type 2 diabetes
Settings: primary care
Intervention: low carbohydrate weight-reducing diets
Comparison: balanced carbohydrate weight-reducing diets
Follow-up: ≥ 12 months
Outcomes Balanced diets Low carbohydrate
diets
Relative effect
(95% CI)
No. of Participants
(studies)
Quality of the evi-
dence
(GRADE)
Illustrative range of
change in average
values from pre-diet
levels by study: range
across studiesa
The effect difference
with low carbohy-
drate diets in ran-
domised comparison
to diets with bal-
anced carbohydrate
(95% CI)
Change in body
weight (kg)
From [value] lower
to [value] kg higher
[value] kg lower
weight
(could
be [value] lower to
[value] higher)
[value]
([value] studies)
⊕©©©
very low
⊕⊕©©
low
⊕⊕⊕©
moderate
⊕⊕⊕⊕
high
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Table 1. Example ’Summary of findings’ table (Continued)
Number of partic-
ipants per group
with weight loss of
at least 5%
[number] per 1000
participants
[number] per 1000
participants
(range)
RR (95% CI) [value]
([value] studies)
⊕©©©
very low
⊕⊕©©
low
⊕⊕⊕©
moderate
⊕⊕⊕⊕
high
Number of partici-
pants per groupwho
died due to cardio-
vascular diseases
[number] per 1000
participants
[number] per 1000
participants
(range)
RR (95% CI) [value]
([value] studies)
⊕©©©
very low
⊕⊕©©
low
⊕⊕⊕©
moderate
⊕⊕⊕⊕
high
Change in
diastolic blood pres-
sure (mmHg)
From [value] lower
to [value] mmHg
higher
[value]
mmHg lower dias-
tolic blood pressure
(could
be [value] lower to
[value] higher)
[value]
([value] studies)
⊕©©©
very low
⊕⊕©©
low
⊕⊕⊕©
moderate
⊕⊕⊕⊕
high
Change in HbA1c
(%)
From [value] lower
to [value] % higher
[value] % lower
HbA1c
(could
be [value] lower to
[value] higher)
[value]
([value] studies)
⊕©©©
very low
⊕⊕©©
low
⊕⊕⊕©
moderate
⊕⊕⊕⊕
high
Change in
serum LDL choles-
terol (mmol/L)
From [value] lower
to [value] mmol/L
higher
[value]
mmol/L lower LDL
cholesterol
(could
be [value] lower to
[value] higher)
[value]
([value] studies)
⊕©©©
very low
⊕⊕©©
low
⊕⊕⊕©
moderate
⊕⊕⊕⊕
high
Participant-re-
ported constipation
[number] per 1000
participants
or
[number] per 1000
participants
(range)
[value]
([value] studies)
⊕©©©
very low
⊕⊕©©
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Table 1. Example ’Summary of findings’ table (Continued)
From [value] lower
to [value] higher
as relevant
or
[value] lower
(could
be [value] lower to
[value] higher)
as relevant
low
⊕⊕⊕©
moderate
⊕⊕⊕⊕
high
CI: confidence interval; HbA1c: glycated haemoglobin; aNote this is the univariate average change observed between follow-up and
baseline in the control group
GRADE Working Group grades of evidence
High quality: further research is very unlikely to change our confidence in the estimate of effect.
Moderate quality: further research is likely to have an important impact on our confidence in the estimate of effect and may change
the estimate.
Low quality: further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to
change the estimate.
Very low quality: we are very uncertain about the estimate.
A P P E N D I C E S
Appendix 1. Preliminary MEDLINE (PubMed) search strategy
#1 Search randomized controlled trial [pt]
#2 Search controlled clinical trial [pt]
#3 Search randomized [tiab]
#4 Search placebo [tiab]
#5 Search clinical trials as topic [mesh: noexp]
#6 Search randomly [tiab]
#7 Search trial [ti]
#8 Search (#1 OR #2 OR #3 OR #4 OR #5 OR #6 OR #7)
#9 Search (animals [mh] NOT humans [mh])
#10 Search (#8 NOT #9)
#11 Search (“low carbohydrate” OR “lower carbohydrate” OR “high fat” OR “higher fat” OR “high protein” OR “higher
protein”)
#12 Search “ketogenic diet”
#13 Search (“carbohydrate restricted” OR “carbohydrates restricted” OR “fat restricted” OR “protein restricted”)
#14 Search (“low carbohydrates” OR “lower carbohydrates”)
#15 Search (“balanced diet” OR “recommended diet”)
#16 Search (“reduced carbohydrate” OR “reduced carbohydrates” OR “reduced fat” OR “reduced protein”)
#17 Search (“macronutrient manipulation” OR “macro nutrient manipulation” OR “macronutrients manipulation” OR “macro
nutrients manipulation”)
#18 Search “ketogenic diets”
#19 Search (#11 OR #12 OR #13 OR #14 OR #15 OR #16 OR #17 OR #18)
#20 Search “Diet, Carbohydrate-Restricted”[Mesh]
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#21 Search “Diet, High-Fat”[Mesh]
#22 Search “Diet, High-Protein Low-Carbohydrate”[Mesh]
#23 Search “Diet, High-Protein”[Mesh]
#24 Search “Diet, Ketogenic”[Mesh]
#25 Search “Diet, Fat-Restricted”[Mesh]
#26 Search “Diet, Mediterranean”[Mesh]
#27 Search (#20 OR #21 OR #22 OR #23 OR #24 OR #25 OR #26)
#28 Search (#19 OR #27)
#29 Search (“weight reducing diet” OR “weight reducing diets” OR “weight loss diet” OR “weight loss diets” OR “calorie
restricted diet” OR “calorie restricted diets” OR “energy restricted diet” OR “energy restricted diets” OR “kilojoule restricted
diet” OR “kilojoule restricted diets”)
#30 Search (“isocaloric diet” OR “hypocaloric diet” OR “isoenergetic diet” OR “hypoenergetic diet”)
#31 Search (“isocaloric diets” OR “hypocaloric diets” OR “isoenergetic diets” OR “hypoenergetic diets”)
#32 Search (“iso caloric diet” OR “hypo caloric diet” OR “iso energetic diet” OR “hypo energetic diet”)
#33 Search (“iso caloric diets” OR “hypo caloric diets” OR “iso energetic diets” OR “hypo energetic diets”)
#34 Search “Diet, Reducing”[Mesh]
#35 Search “Caloric Restriction”[Mesh]
#36 Search (#29 OR #30 OR #31 OR #32 OR #33 OR #34 OR #35)
#37 Search (#10 AND #28 AND #36)
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